454 Life Sciences and Genomequest have announced a co-marketing agreement that will see Genomequest offer its on-demand informatics service to 454 Genome Sequencer FLX system users.
Genomequest's high-throughput annotation and data management tools enable rapid characterisation of sequences generated by the Genome Sequencer FLX system.
The companies said the combination of the Genome Sequencer FLX system's sequence results and Genomequest's informatics tools increases speed and convenience in converting the increasing volume of sequence data into biologically meaningful information.
The co-marketing agreement resulted from pilot activities conducted to evaluate the scientific accuracy and scalability of Genomequest's algorithms and informatics platform.
The goal was to assess the value that Genomequest could provide Genome Sequencer FLX system users.
